反応 #40649
ord-4ff04c5e94c1429fb6e2c8b432ea5d8a
反応方程式
aminoalcohol
4-[1-Amino-2-(4-fluorophenyl)-ethyl]-4-hydroxypiperidine-1-carboxylic acid benzyl ester
NaI
chloroacetylchloride
iodide
tert-butoxide
→
title compound
収率 19.0%
5-(4-Fluorobenzyl)-3-oxo-1-oxa-4,9-diaza-spiro[5.5]undecane-9-carboxylic acid benzyl ester
収率 19.0%
反応物
試薬
なし
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1その他Purification of the crude product by silica gel column chromatography
- 2洗浄eluting with a stepwise gradient of 0-100% ethyl acetate in n-heptane
実験手順
The title compound was prepared from aminoalcohol 103NLS28 (303 mg, 0.81 mmol) according to literature procedures (Clark et al., J. Med. Chem. 26:855-861 (1983)), by acylation of the amino function with chloroacetylchloride, followed by halogen exchange with NaI and ring closure of the iodide derivative in presence of tert-butoxide. Purification of the crude product by silica gel column chromatography, eluting with a stepwise gradient of 0-100% ethyl acetate in n-heptane, afforded the title compound (64 mg, 19% overall yield) as a colourless solid.